Concepedia

Anna-Karin Sjögren

AS

18

Publications

1.1K

Citations

17

H-Index

1980

Active since

Affiliations

AstraZeneca (Sweden)(Current)

University of Gothenburg

Qilu Hospital of Shandong University

Sahlgrenska University Hospital

University of California, Los Angeles

Anna-Karin Sjögren is an author at AstraZeneca (Sweden) specializing in medicine, cell biology, and developmental biology.

ORCID

Top concepts

Publications per year

1980–2022

18

Publications

18

GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer

Anna-Karin Sjögren, Karin Andersson, Meng Liu et al. · Journal of Clinical Investigation · 2007 · 115 citations · Full text

Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer

Meng Liu, Anna-Karin Sjögren, Christin Karlsson et al. · Proceedings of the National Academy of Sciences · 2010 · 111 citations · Full text

Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice

Omar M. Khan, Mohamed X. Ibrahim, Ing‐Marie Jonsson et al. · Journal of Clinical Investigation · 2011 · 110 citations · Full text

, , +25

Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes

Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragán et al. · Drug Metabolism and Disposition · 2014 · 98 citations

Internalization of cellular fragments in a human embryo: time-lapse recordings

Thorir Hardarson, Carl O. Löfman, Graham D. Coull et al. · Reproductive BioMedicine Online · 2002 · 95 citations · Full text

, , +8

Rows per page

1–5 of 18